Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 1 1

Status

Completed 17Unknown 6Recruiting 6Terminated 5Active not recruiting 4Withdrawn 3Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 4Tumor-Agnostic 1Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 4Uterine Cervical Dysplasia 2Neoplasms 2Precancerous Conditions 1Papilloma 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Colposcopy × Clear all
NCT00250055 2024-03-12

Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue

University of New Mexico

Phase NA Terminated
100 enrolled
Tumor-Agnostic

Neoplasms

NCT01234480 2023-05-16

Intended Use Study of the BD SurePath Plusâ„¢ Pap

Becton, Dickinson and Company

Terminated
5,859 enrolled 4 charts
Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Neoplasms, Squamous Cell

NCT03020121 2018-01-31

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Becton, Dickinson and Company

Phase NA Terminated
28 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00629577 2017-02-01

SAGE

British Columbia Cancer Agency

Phase 1 Terminated
50 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00529464 2016-05-09

Spectroscopy Versus Standard Care in Cervical Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Terminated
2 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡